Please Wait.....
Report
South Korea Immunoglobulin Market Forecast 2022-2028
Market Report I 2022-06-28 I 149 Pages I Inkwood Research
KEY FINDINGS
The South Korea immunoglobulin market is predicted to project a CAGR of 8.11% during the estimated years. While the base year regarded for the market study is 2021, the forecast period is from 2022 to 2028. The main factors promoting the market growth of the country are the prevalence of different diseases and disorders due to weak immune systems as well as the increasing geriatric population.
MARKET INSIGHTS
Immunoglobulins entail antibodies that are naturally produced by the immune system of the body. They primarily help fight diseases and infections. The glycoprotein molecules are created by plasma cells and represent a vital component of the body's immune response. Immunoglobulins precisely recognize and bind to particular antigens, such as viruses and bacteria, while stimulating their obliteration.
According to statistics, the elderly population in South Korea equated to nearly 3.51 million males and 4.61 million females in 2020. This figure is set to rise and reach approximately 9.84 million females and 8.98 million males by the year 2060. Hence, the significant increase in the geriatric population is projected to heighten the incidence of various disorders and diseases on account of weak immune systems. This factor, subsequently, will boost the demand for immunoglobulin products for treatments. As a result, the aforementioned drivers are set to influence the immunoglobulin market growth in South Korea over the forecast period.
COMPETITIVE INSIGHTS
The top firms operating in the market include Green Cross, ABL Bio, Celltrion, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation cater to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. COUNTRY SNAPSHOT
2.4. COUNTRY ANALYSIS
2.5. KEY GROWTH ENABLERS
2.6. KEY CHALLENGES
3. KEY ANALYTICS
3.1. IMPACT OF COVID-19 ON IMMUNOGLOBULIN MARKET
3.2. KEY MARKET TRENDS
3.3. PORTER'S FIVE FORCES ANALYSIS
3.3.1. BUYERS POWER
3.3.2. SUPPLIERS POWER
3.3.3. SUBSTITUTION
3.3.4. NEW ENTRANTS
3.3.5. INDUSTRY RIVALRY
3.4. OPPORTUNITY MATRIX
3.5. PESTLE ANALYSIS
3.6. KEY BUYING CRITERIA
3.6.1. SOURCE
3.6.2. APPLICATION
3.6.3. EPITOPE
3.6.4. VALIDATION
4. MARKET BY PRODUCT
4.1. IGG
4.2. IGA
4.3. IGM
4.4. IGE
4.5. IGD
5. MARKET BY MODE OF DELIVERY
5.1. INTRAVENOUS IMMUNOGLOBULIN
5.2. SUBCUTANEOUS IMMUNOGLOBULIN
5.3. INTRAMUSCULAR IMMUNOGLOBULIN
6. MARKET BY APPLICATION
6.1. HYPOGAMMA GLOBULINEMIA
6.2. CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
6.3. PRIMARY IMMUNODEFICIENCY DISEASES
6.4. MYASTHENIA GRAVIS
6.5. MULTIFOCAL MOTOR NEUROPATHY
6.6. IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
6.7. INFLAMMATORY MYOPATHIES
6.8. SPECIFIC ANTIBODY DEFICIENCY
6.9. GUILLAIN-BARRE SYNDROME
6.10. OTHER APPLICATIONS
7. MARKET BY DISTRIBUTION CHANNEL
7.1. HOSPITAL PHARMACY
7.2. SPECIALTY PHARMACY
7.3. OTHER DISTRIBUTION CHANNELS
8. MARKET BY END-USER
8.1. HOSPITALS & CLINICS
8.2. HOMECARE
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ABL BIO
9.2.2. CELLTRION
9.2.3. GREEN CROSS
9.2.4. ORUM
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - IMMUNOGLOBULIN
TABLE 2: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 3: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY PRODUCT, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 4: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY MODE OF DELIVERY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY MODE OF DELIVERY, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 6: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY APPLICATION, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 8: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 10: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY END-USER, FORECAST YEARS, 2022-2028 (IN $ MILLION)
TABLE 12: LIST OF MERGERS & ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: KEY BUYING CRITERIA
FIGURE 5: SOUTH KOREA IMMUNOGLOBULIN MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021
FIGURE 6: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY IGG, 2022-2028 (IN $ MILLION)
FIGURE 7: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY IGA, 2022-2028 (IN $ MILLION)
FIGURE 8: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY IGM, 2022-2028 (IN $ MILLION)
FIGURE 9: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY IGE, 2022-2028 (IN $ MILLION)
FIGURE 10: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY IGD, 2022-2028 (IN $ MILLION)
FIGURE 11: SOUTH KOREA IMMUNOGLOBULIN MARKET, GROWTH POTENTIAL, BY MODE OF DELIVERY, IN 2021
FIGURE 12: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY INTRAVENOUS IMMUNOGLOBULIN, 2022-2028 (IN $ MILLION)
FIGURE 13: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2022-2028 (IN $ MILLION)
FIGURE 14: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2022-2028 (IN $ MILLION)
FIGURE 15: SOUTH KOREA IMMUNOGLOBULIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021
FIGURE 16: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY HYPOGAMMA GLOBULINEMIA, 2022-2028 (IN $ MILLION)
FIGURE 17: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, 2022-2028 (IN $ MILLION)
FIGURE 18: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY PRIMARY IMMUNODEFICIENCY DISEASES, 2022-2028 (IN $ MILLION)
FIGURE 19: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY MYASTHENIA GRAVIS, 2022-2028 (IN $ MILLION)
FIGURE 20: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY MULTIFOCAL MOTOR NEUROPATHY, 2022-2028 (IN $ MILLION)
FIGURE 21: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), 2022-2028 (IN $ MILLION)
FIGURE 22: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY INFLAMMATORY MYOPATHIES, 2022-2028 (IN $ MILLION)
FIGURE 23: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY SPECIFIC ANTIBODY DEFICIENCY, 2022-2028 (IN $ MILLION)
FIGURE 24: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY GUILLAIN-BARRE SYNDROME, 2022-2028 (IN $ MILLION)
FIGURE 25: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)
FIGURE 26: SOUTH KOREA IMMUNOGLOBULIN MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2021
FIGURE 27: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY HOSPITAL PHARMACY, 2022-2028 (IN $ MILLION)
FIGURE 28: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY SPECIALTY PHARMACY, 2022-2028 (IN $ MILLION)
FIGURE 29: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY OTHER DISTRIBUTION CHANNELS, 2022-2028 (IN $ MILLION)
FIGURE 30: SOUTH KOREA IMMUNOGLOBULIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
FIGURE 31: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY HOSPITALS & CLINICS, 2022-2028 (IN $ MILLION)
FIGURE 32: SOUTH KOREA IMMUNOGLOBULIN MARKET, BY HOMECARE, 2022-2028 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security